Komori
Treasury Shares6090Human Metabolome Technologies,Inc.Information and Communications, Services and Others

Notice Regarding the Status of Share Repurchases

In May 2026, the company acquired 69,200 treasury shares for approximately ¥45.07 million. Cumulative acquisitions under the board resolution totaled 142,900 shares for approximately ¥98.03 million.

Worth reading
49Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
45070900
¥
Wording
Definitive
How definitive the wording is.

Progress against acquisition limit

Market purchases on the Tokyo Stock Exchange

Resolved 12 February 2026 / Acquisition period 13 February 2026 to 31 December 2026

57.2%
Cumulative utilization rate
Limit107,100 株 remaining
Number of Shares250,000 shares (maximum)
—
No Track Record Reported
Limit
Amount¥200 million (maximum)

The darker band is the portion acquired this time (1 May 2026 to 31 May 2026 (on a trade-date basis)).

Number of Shares
Limit250,000 shares (maximum)
Cumulative total142,900 shares (as of 31 May 2026)
Current69,200 shares
Amount
Limit¥200 million (maximum)
Cumulative total¥98,025,500 (as of 31 May 2026)
Current¥45,070,900
Percentage of total issued shares4.4% (as a percentage of the total number of issued shares excluding treasury shares)
Average acquisition price for this transaction (calculated)¥651 per shareCurrent acquisition price ÷ current number of shares acquired

消化率と残りは、会社が示した累計・今回と上限から算出しています。進捗率=上限に対してどこまで使ったかの割合です。

Progress against acquisition limit
ItemDetails
Total number of shares acquired in this transaction69,200 shares
Total current acquisition price¥45,070,900
Acquisition date/acquisition period1 May 2026 to 31 May 2026 (on a trade-date basis)
Method of acquisitionMarket purchases on the Tokyo Stock Exchange
Cumulative number of shares acquired142,900 shares (as of 31 May 2026)
Cumulative acquisition cost¥98,025,500 (as of 31 May 2026)
Resolution date12 February 2026
Maximum number of shares to be acquired250,000 shares (maximum)
Total acquisition price¥200 million (maximum)
Acquisition period under the resolution13 February 2026 to 31 December 2026
Percentage of total issued shares4.4% (as a percentage of the total number of issued shares excluding treasury shares)
Items this document does not state (2)
Whether acquisition has been completedAverage Acquisition Price

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To report the status of the acquisition. No specific reason for acquiring treasury shares is stated.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Status of Share Repurchases | Human Metabolome Technologies,Inc. (6090) timely disclosure | Komori